The Weekly Roundup: February 24-28

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Ethical Considerations and Guidance of Cosmeceuticals in Pediatric Care

The promotion of anti-aging products to children, who don't yet experience age-related skin changes, is both ethically questionable and potentially harmful.

Phase 3 Trial Supports Roflumilast for Pediatric AD

Lead author on recent research, Lawrence Eichenfield, MD, said if approved, this treatment could fill a “significant gap.”

Sunscreen is the Best Way to Prevent Post-Inflammatory Hyperpigmentation in Skin of Color

Although more research is needed to fill this gap, sunscreen had the greatest success rates of all the prevention methods in this literature review.

Laser and Bimatoprost Combination Therapy Improve Facial Vitiligo

Findings suggest that this novel treatment approach can enhance the quality of life for vitiligo patients without increasing the risk of adverse events.

Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases

Ustekinumab-kfce is available for the treatment of chronic autoimmune conditions like Crohn’s disease, ulcerative colitis, and plaque psoriasis.

How the LIMITLESS Initiative Supports Female Leaders in Dermatology

Mindy Haws, MD, spoke to Dermatology Times about the new videos, podcasts, and other resources LIMITLESS offers for women at all stages of their careers.

Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring

Researchers reported that propranolol initiation for infantile hemangiomas in pediatric patients is safe, with no significant complications, suggesting reduced need for intensive monitoring.

Current Clinical and Aesthetic Applications of Snail Mucin

Snail slime contains bioactive compounds that promote skin healing, hydration, and regeneration.

Alcohol Consumption and Other Lifestyle Factors May Contribute to Melasma

The case-control Chinese study evaluated circumstances that have previously never been established as potential melasma causes.

New Study Supports SSA for Rosacea Treatment

Patients receiving SSA treatments showed significant improvements after just 2 sessions, supporting its rapid efficacy.

Reviewing Complex Cases: Topicals for Pediatric AD

At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a female patient aged 12 years with moderate AD that had been worsening over the past several months.

LIMITLESS: A Collaborative Effort Between Allergan, The Aesthetic Society, and The American Society of Plastic Surgeons

This collective initiative gives Mindy Haws, MD, and her team the ability to reach more women in a way that gives back and helps them succeed.

Journal Digest: February 26

In this week's edition of the Journal Digest, we review the latest dermatologic insights into cardiovascular outcomes in psoriasis patients, the rationales of cold plasma jet therapy in skin cancer, and more.

Nonsteroidal Approaches to Chronic and Severe Atopic Dermatitis

In a recent Dermatology Times Case-Based Roundtable custom event, “Beyond Steroids: Exploring Topical and Nonsteroidal Therapies for Atopic Dermatitis,” Robert Casquejo, PA-C, focused on real-world patient cases of atopic dermatitis (AD) in a conversation with fellow dermatology professionals.

The Promise and Challenges of Augmented and Virtual Reality in Medicine

Lead investigator Leon Kircik, MD, emphasized the need for collaboration between clinicians, technologists, and policymakers to maximize VR/AR’s potential.

FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD

A PDUFA target action date has been set for October 13, 2025

Patients with Androgenetic Alopecia Have a Higher Risk of Depression

A two-set Mendelian randomization analysis revealed a genetic correlation between depression and androgenetic alopecia.

Diamant Thaçi, MD, PhD: Understanding the Impact of Nemolizumab Efficacy Post Approvals in EU, UK, and Switzerland

Professor Diamant Thaçi, MD, PhD, discusses findings from the ARCADIA and OLYMPIA clinical trial programs, highlighting nemolizumab’s rapid efficacy in treating atopic dermatitis and prurigo nodularis.

Independent Pharmacy Overcomes Crisis with Community and Telehealth Help

Well Revolution’s partnership with City Chemist highlights how telehealth can sustain small businesses and improve patient care.

Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN

Christophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.

How Mindy Haws, MD, Empowers Women in Aesthetic Medicine

Haws offers advice to female clinicians about leadership, collaboration, and the future of the aesthetics industry.

Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally

Christophe Piketty, MD, PHD, discusses the promising efficacy, novel mechanisms, and patient benefits of nemolizumab in targeting IL-31 for atopic dermatitis and psoriasis.

Interview Intersection: Expert Interviews From February 2025

Dermatology Times is recapping our top expert interviews from the month of February.

A Case-Based Approach to Topical and Nonsteroidal AD Management

Nonsteroidal AD therapies are gaining attention due to their rapid effectiveness and ability to offer an alternative to long-term steroid use.

LEO Pharma Reports Positive Results in Delgocitinib Trial for CHE

DELTA China follows the success of European and Canadian trials, reinforcing delgocitinib’s potential as a global treatment for CHE.

Quoin Reports Positive QRX003 “Whole Body” Pediatric Data for Netherton Syndrome

After just 2 weeks of twice-daily use, a pediatric patient saw visually improved skin with no adverse events.

The Importance of Community in Health Care

Independent pharmacies are closing at high rates, leaving many communities without essential health care access.

Dermatology Times February 2025 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of February.

A “Step-Down” Approach May Be More Effective for Younger Patients with Psoriasis

Belgian patients receiving biologics had faster response rates compared to phototherapy, systemic, and topical treatments.

Are AD Severity Tools Essential in Routine Practice?

Objective tools like IGA and EASI provide structured severity assessment but often lack patient-reported insights such as itch severity.

SLIDESHOW: A Look at 5 Rare Skin Conditions

Today, Dermatology Times recognizes Rare Disease Day in an effort to amplify the voices of the over 300 million individuals affected by rare diseases.

Dermatology Times February 2025 Print Recap

Learn more about the in-depth topics covered in the February 2025 print issue of Dermatology Times.

Case-Based Insights on Ruxolitinib vs Corticosteroids for Atopic Dermatitis

At a recent Dermatology Times Case-Based Roundtable event, James Q. Del Rosso, DO, discussed the limitations of topical corticosteroids and the benefits of nonsteroidals.

Celebrating Black History Month 2025 with Dermatology Times

Review our content from the month of February that recognizes patients and clinicians with skin of color.

POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation

Share your thoughts by answering today’s poll and read about these popular aesthetic techniques for lips.

Top 5 Articles of the Month: February

Explore the top headlines of the month including the expanding role of NPs and PAs, a guide to 2025 conferences, and expert insights from Paul Friedman, MD.